In addition, IHC results showed that the area of cleaved caspase 3 staining was approximately 75% of the tumor mass in the 2DG‐treated 4T1 tumor model, which was more than three times that in the control groups (Figure 5c). This evidence concerns the gene CASP3 and neoplasm.